April 3, 2014
The National Association of Cannabis Pharmacy (NACP) launched today during the Specialty Pharmacy EXPO, hosted by the National Association of Specialty Pharmacy (NASP), in Tampa.
The purpose of the new association is to support pharmacists who dispense, administer and compound cannabis-based products to treat specialty diseases including multiple sclerosis, HIV, oncology and Rheumatoid arthritis, according to an NASP press release.
“The focus has to be on the patient and how they are receiving guidance and education to manage conditions in which medical marijuana is incorporated as part of the treatment plan,” Joseph Friedman RPh., MBA said. “There is an immediate need for the development of advanced training and parameters for pharmacists to lead the process.”
Initially, the NACP will focus on building an educational platform focused on the compounding, administration and use of medical marijuana for specialty therapeutic categories. Through the NACP, pharmacists will receive the necessary training to utilize cannabis for concomitant therapy, specifically in the retail channel. NACP will also investigate the development of an accreditation program for pharmacies and a professional certification program for pharmacists.
“The legislation guiding the use of medical marijuana varies by state and does not include the pharmacist in a role that allows them to use their knowledge and expertise to protect the patient and improve their outcomes,” Mathew Sherwood, NACP Cannabis Industry Consultant, said. “This is an opportunity to close that gap.”